Catalyst Wire Dossier Catalyst Wire Dossier

Epimedium Prenylflavonoid (EP) Extract

Epimedium prenylflavonoid extract · National University Hospital, Singapore
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epimedium Prenylflavonoid (EP) Extract, covering 2016-10-14 to 2016-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease [Phase 1]

See pricing